🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an investigator-initiated study of safety, efficacy and tolerabilit...
Status
Completed
Location
Deaconess Clinic Gateway Health Center
Start Date
2009-07
Trial ID
NCT00939120
Treatments Being Tested
To investigate if oxybutynin ER adding on antimuscarinics is more effective...
Status
Completed
Location
Buddhist Tzu Chi General Hospital
Start Date
2013-03
Trial ID
NCT01824420
Treatments Being Tested
The objective of this study was to investigate the single-dose relative bio...
Status
Completed
Location
Kendle International Inc.
Start Date
2002-07
Trial ID
NCT00649129
Treatments Being Tested
The purpose of the study is to assess the impact of treatment with tolterod...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-03
Trial ID
NCT00143481
Treatments Being Tested
This study is designed to evaluate the safety, tolerability, and efficacy o...
Status
Completed
Location
Coastal Clinical Research Inc.
Start Date
2018-06-14
Trial ID
NCT03583372
Treatments Being Tested
This study is designed to evaluate the safety, tolerability, and efficacy o...
Status
Completed
Location
Central Alabama Research
Start Date
2018-03-26
Trial ID
NCT03492281
Treatments Being Tested
The primary purpose of the trial is to show that tolterodine ER has no effe...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-12
Trial ID
NCT00411437
Treatments Being Tested
For many years, antimuscarinics have been first-line pharmacological treatm...
Status
Completed
Location
Samsung Medical Center
Start Date
2009-02
Trial ID
NCT00836381
Treatments Being Tested
The objective of this study was to investigate the single-dose relative bio...
Status
Completed
Location
Kendle International Inc.
Start Date
2002-07
Trial ID
NCT00649727
Treatments Being Tested
Patients with overactive bladder are often treated with tolterodine, a medi...
Status
Completed
Location
Radiant Research, Inc.
Start Date
2011-05
Trial ID
NCT01302054
Treatments Being Tested